Results 1 to 10 of about 237 (112)

Cognitive deficits in patients with peripheral vestibular dysfunction. [PDF]

open access: yesEur J Neurol
Abstract Background and purpose Previous studies demonstrated cognitive deficits in patients with peripheral vestibulopathy (PVP) with dysfunction of spatial navigation and orientation, but also documented cognitive decline in nonspatial abilities.
Obermann M   +8 more
europepmc   +5 more sources

Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular dementia: A randomized clinical trial. [PDF]

open access: yesAlzheimers Dement (N Y), 2018
Abstract Introduction No licensed medications are available to treat vascular dementia (VaD). Methods Patients were randomly assigned to experimental groups (SaiLuoTong [SLT] 360 or 240 mg for groups A and B for 52 weeks, respectively) or placebo group (SLT 360 mg and 240 mg for group C only from weeks 27 to 52, respectively).
Jia J   +19 more
europepmc   +5 more sources

EXIT25 - Executive interview applied to a cognitively healthy elderly population with heterogeneous educational background [PDF]

open access: yesDementia & Neuropsychologia, 2008
Education interferes with the performance in most cognitive tests, including executive function assessment. Objective: To investigate the effects of education on the performance of healthy elderly on the Brazilian version of the Executive Interview ...
Maria Niures P.S. Matioli   +6 more
doaj   +5 more sources

Arsenic exposure, AS3MT polymorphism, and neuropsychological functioning among rural dwelling adults and elders: a cross-sectional study. [PDF]

open access: yesEnviron Health, 2014
This article aims to examine the link between low-level arsenic exposure and cognitive functioning, and the potential role of a single nucleotide polymorphism (SNP A35991G, rs10748835) of the AS3MT gene in modifying this ...
Edwards M, Hall J, Gong G, O'Bryant SE.
europepmc   +6 more sources

A depressive endophenotype of mild cognitive impairment and Alzheimer's disease. [PDF]

open access: yesPLoS ONE, 2013
BackgroundAlzheimer's disease (AD) is a devastating public health problem that affects over 5.4 million Americans. Depression increases the risk of Mild Cognitive Impairment (MCI) and AD.
Leigh A Johnson   +2 more
doaj   +2 more sources

Hearing Loss and Cognitive Decline in the Aging Population: Emerging Perspectives in Audiology. [PDF]

open access: yesAudiol Res
In this perspective article, the author explores the connections between hearing loss, central auditory processing, and cognitive decline, offering insights into the complex dynamics at play.
Nagaraj NK.
europepmc   +3 more sources

Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. [PDF]

open access: yesCochrane Database Syst Rev, 2021
BACKGROUND: Vascular cognitive impairment (VCI) describes a broad spectrum of cognitive impairments caused by cerebrovascular disease, ranging from mild cognitive impairment to dementia.
Battle CE   +4 more
europepmc   +4 more sources

Repurposing Proteostasis-Modifying Drugs to Prevent or Treat Age-Related Dementia: A Systematic Review. [PDF]

open access: yesFront Physiol, 2018
Background: Dementia has a significant impact on quality of life of older individuals. Impaired proteostasis has been implicated as a potential cause of dementia, that can be therapeutically targeted to improve patient outcomes.
Heard DS   +3 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy